State · Mississippi

Attorney General James Secures Over $9 Million for New York from Abbott Laboratories for Manufacturing Potentially Unsafe Baby Formula

Attorney General James Secures Over $9 Million for New York from Abbott Laboratories for Manufacturing Potentially Unsafe Baby Formula

Attorney General James Secures Over $9 Million for New York from Abbott Laboratories for Manufacturing Potentially Unsafe Baby Formula

Attorney General Brown Seeks Court Approval for $400 Million Multistate Settlement with Sandoz over Alleged Conspiracy to Inflate Prices and Limit Competition Published: 10/1/2026

CMS Announces New Preliminary Medicare Payment Rates for Laboratory Services, Saving Taxpayers an Estimated $1 Billion Annually

Attorney General Brenna Bird Seeks Court Approval for $400 Million Settlement with Sandoz for Overcharging for Generic Drugs and Limiting Competition

Attorney General Tong Seeks Court Approval for $400 Million Settlement With Sandoz Over Conspiracy to Inflate Prices and Limit Competition

CMS Announces Participants in Landmark Medicaid Drug Payment Model to Bring Down Drug Costs for Most Vulnerable Americans

Attorney General Hilgers Seeks Court Approval for Settlements with Ascend, Citron, and Mayne Over Conspiracy to Inflate Prices and Limit Competition

MLN Connects Newsletter for May 7, 2026

Attorney General Hilgers Seeks Court Approval for Settlements with Ascend, Citron, and Mayne Over Conspiracy to Inflate Prices and Limit Competition

October 08, 2026 ATTORNEY GENERAL RAOUL SEEKS COURT APPROVAL FOR NATIONWIDE SETTLEMENTS WITH ASCEND, CITRON AND MAYNE OVER CONSPIRACY TO RAISE GENERIC DRUG PRICES AND LIMIT COMPETITION

Attorney General Aaron M. Frey Seeks Court Approval for Settlements with Ascend, Citron, and Mayne Pharma Over Conspiracy to Inflate Prices and Limit Competition

Attorney General Clark Seeks Court Approval for $358,000 Settlement with Sandoz Over Conspiracy to Inflate Prices and Limit Competition

Colorado slated to receive $2.1M from nationwide settlement with Sandoz over illegal generic drug price hikes and collusion

Home Healthcare Worker Charged with Unlicensed Practice of Medicine, Identity Theft

Attorney General Brown Seeks Court Approval for Multistate Settlements with Ascend, Citron and Mayne Over Conspiracy to Inflate Prices and Limit Competition Published: 10/9/2026

Coalition Seeks Court Approval for Settlement With Ascend, Citron, and Mayne Pharma Over Conspiracy to Inflate Generic Drug Prices

MLN Connects Newsletter for September 17, 2026

Attorney General Alan Wilson urges consumers to claim compensation for inflated generic drug pricesRead More

Washington settles generic drug cases with Ascend Laboratories, Citron Pharma, and Mayne Pharma

Acting Alaska Attorney General Cori Mills Seeks Court Approval for Settlements with Ascend, Citron and Mayne Over Conspiracy to Inflate Prices and Limit Competition

Press Release OCT 8, 2026 AG Sunday’s Antitrust Section Seeks Court Approval for Settlements with 3 Generic Drug Makers Regarding Price Inflation HARRISBURG, Attorney General Dave Sunday joined a coalition of 45 states and territories seeking court approval of three settlements with Ascend Laboratories, Citron Pharma, and Mayne Pharma… Read more

MS HB 565: Health benefit plans and Medicaid; require to offer coverage for biomarker testing.

Washington, multistate coalition seek approval for $400 million settlement in drug price-fixing case

Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I

Attorney General Hilgers Seeks Court Approval for Settlements with Ascend, Citron, and Mayne Over Conspiracy to Inflate Prices and Limit Competition

Attorney General Tong Seeks Court Approval for Settlements with Ascend, Citron and Mayne Over Conspiracy to Inflate Prices and Limit Competition

Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS) and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year (FY) 2027 Rates; Requirements for Quality Programs; Other Policy Changes; and Adoption of Updated Versions of Certain Health Information Technology Standards; Correction

Attorney General Brown Urges Consumers to Claim Compensation for Inflated Generic Drug Prices Published: 9/23/2026

Attorney General Jackley Requests Court Approval Of South Dakota Settlement with Sandoz Inc.

Wisconsin Department of Justice Urges Consumers to Claim Compensation for Inflated Generic Drug Prices

Attorney General Jackley Settles with Three Additional Generic Drug Companies on Price Fixing

Attorney General Knudsen urges Montanans to claim compensation for inflated generic drug prices

Attorney General Mike Hilgers Urges Consumers to Claim Compensation for Inflated Generic Drug Prices

Attorney General Jackley Urges SD Consumers to Claim Compensation for Inflated Generic Drug Prices

AG Campbell Seeks Court Approval For Settlements With Generic Drug Manufacturers Over Conspiracy To Inflate Prices And Limit Competition

Attorney General Clark Encourages Eligible Consumers to Claim Compensation for Inflated Generic Drug Prices

Attorney General Aaron M. Frey Urges Consumer to Claim Compensation for Inflated Generic Drug Prices

Following Settlements With Generic Drug Manufacturers, AG's Office Urges Consumers To Claim Compensation For Inflated Generic Drug Prices

WA consumers urged to claim compensation for inflated generic drug prices

Generic Drug Settlement Distribution

Attorney General Tong Urges Consumers to Claim Compensation for Inflated Generic Drug Prices

Attorney General Rayfield Secures Patient Relief Over Inflated Drug Prices

Utah Consumers Claim Compensation Inflated Generic Drugs

Tennessee Joins 20-State Coalition Warning of National Security Risks in Pharmaceutical Supply Chain

Health Center Program Performance Period Extensions

Attorney General Bonta Urges Consumers to Claim Compensation for Inflated Generic Drug Prices